These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21617269)

  • 1. [Purposefulness of using fuzzy logic approaches in the rare disease clinical trials].
    Kiseleva TS; Pagava KI; Korinteli IA; Korinteli MG; Shonvadze DN
    Georgian Med News; 2011 Apr; (193):22-4. PubMed ID: 21617269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the logic in mixing data and beliefs?
    Brown PM
    Pharm Stat; 2007; 6(1):5-8. PubMed ID: 17256805
    [No Abstract]   [Full Text] [Related]  

  • 3. Sample size reestimation by Bayesian prediction.
    Wang MD
    Biom J; 2007 Jun; 49(3):365-77. PubMed ID: 17623342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuzzy logic alternative for analysis in the biomedical sciences.
    Virant-Klun I; Virant J
    Comput Biomed Res; 1999 Aug; 32(4):305-21. PubMed ID: 10469527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management options for rare diseases in children and adolescents in Georgia (experience of the country with transitional economy).
    Pagava K; Abesadze G; Uberi N; Korinteli I; Paghava I; Kvezereli-Kopadze M; Parulava T; Korinteli M; Kiseliova T
    Georgian Med News; 2011 Apr; (193):8-11. PubMed ID: 21617265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistics and the relationship of clinical research to clinical practice.
    Khuder SA; Kahaleh B
    J Rheumatol; 2009 Feb; 36(2):219-20. PubMed ID: 19208555
    [No Abstract]   [Full Text] [Related]  

  • 7. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma.
    Johnson SR; Feldman BM; Pope JE; Tomlinson GA
    J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic and fuzzy logic in clinical diagnosis.
    Licata G
    Intern Emerg Med; 2007 Jun; 2(2):100-6. PubMed ID: 17634817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need to improve clinical trials in rare neurodegenerative disorders.
    Puopolo M; Pocchiari M
    Ann Ist Super Sanita; 2011; 47(1):55-9. PubMed ID: 21430340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paradigms and pragmatism].
    Healy MJ
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):185-9. PubMed ID: 10367305
    [No Abstract]   [Full Text] [Related]  

  • 11. Bayesian clinical trials.
    Berry DA
    Nat Rev Drug Discov; 2006 Jan; 5(1):27-36. PubMed ID: 16485344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian analysis of hierarchical pattern-mixture models for clinical trials data with attrition and comparisons to commonly used ad-hoc and model-based approaches.
    Demirtas H
    J Biopharm Stat; 2005; 15(3):383-402. PubMed ID: 15920887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noise image segmentation based on generalized fuzzy Gibbs random field].
    Gong J; Zhang Y; Chen WF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):390-3. PubMed ID: 16624734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Roaming through methodology. XXXVI. Likelihood ratios and Bayes' rule].
    Vermeulen M
    Ned Tijdschr Geneeskd; 2001 Dec; 145(50):2421-4. PubMed ID: 11776667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When less is more: using shrinkage to increase accuracy.
    Wears RL; Normand SL
    Ann Emerg Med; 2010 Jun; 55(6):553-5. PubMed ID: 20494223
    [No Abstract]   [Full Text] [Related]  

  • 16. Fuzzy least squares for identification of individual pharmacokinetic parameters.
    Seng KY; Nestorov I; Vicini P
    IEEE Trans Biomed Eng; 2009 Dec; 56(12):2796-805. PubMed ID: 19695981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust fuzzy mappings for QSAR studies.
    Kumar M; Thurow K; Stoll N; Stoll R
    Eur J Med Chem; 2007 May; 42(5):675-85. PubMed ID: 17316911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
    De Luca A; Vendittelli M; Baldini F; Di Giambenedetto S; Trotta MP; Cingolani A; Bacarelli A; Gori C; Perno CF; Antinori A; Ulivi G
    Antivir Ther; 2004 Aug; 9(4):583-93. PubMed ID: 15456090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials and rare diseases.
    Lagakos SW
    N Engl J Med; 2003 Jun; 348(24):2455-6. PubMed ID: 12802033
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis support system based on clinical guidelines: comparison between case-based fuzzy cognitive maps and Bayesian networks.
    Douali N; Csaba H; De Roo J; Papageorgiou EI; Jaulent MC
    Comput Methods Programs Biomed; 2014; 113(1):133-43. PubMed ID: 24599907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.